Croda

Croda International Plc, a specialty chemical company providing high purity and high quality excipients for drug and vaccine development, has recently strengthened their offering with significant investment in the area of vaccine adjuvants. Providing customers with over 80 years of adjuvant expertise, our Vaccine Adjuvants Division (formerly Benntag Biosector) has unprecedented industry experience as a vaccine adjuvant specialist. In addition to supplying industry renowned aluminium- and saponin-based adjuvants, including the well-known brands Alhydrogel®, Adju-Phos® and Quil-A®, Croda is committed to developing the next generation of adjuvant technology, with a robust innovation pipeline focusing on enhanced protein binding and immune-stimulating nanotechnology. Additionally, this year Croda has acquired Avanti Polar Lipids, extending its portfolio and expertise in the area of vaccine adjuvants and immunology. Engage with our team today to learn more about how we can help you with your vaccine development needs!